{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 458780973
| IUPAC_name = ''trans''-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione
| image = Atovaquone Structural Formula V.1.svg
| width = 215
| image2 = Atovaquone_sf.png

<!--Clinical data-->
| tradename = Mepron
| Drugs.com = {{drugs.com|monograph|atovaquone}}
| MedlinePlus = a693003
| pregnancy_category =
| legal_US = Rx
| legal_UK = POM
| routes_of_administration = [[Oral administration|By mouth]]

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life = 2.2–3.2 days

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 95233-18-4
| ATC_prefix = P01
| ATC_suffix = AX06
| ATC_supplemental =  
| PubChem = 74989
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01117
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 10482034
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Y883P1Z2LT
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00236
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 575568
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1450

<!--Chemical data-->
| C=22 | H=19 | Cl=1 | O=3
| molecular_weight = 366.837 g/mol
| smiles = OC=2C(=O)c1ccccc1C(=O)C=2[C@@H]3CC[C@H](CC3)c4ccc(Cl)cc4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H19ClO3/c23-16-11-9-14(10-12-16)13-5-7-15(8-6-13)19-20(24)17-3-1-2-4-18(17)21(25)22(19)26/h1-4,9-13,15,26H,5-8H2/t13-,15-
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = KUCQYCKVKVOKAY-CTYIDZIISA-N
}}

'''Atovaquone''' (alternative spelling: '''atavaquone''') is a chemical compound that belongs to the class of [[naphthoquinone]]s. Atovaquone is a hydroxy-1,4-naphthoquinone, an analog of [[ubiquinone]], with antipneumocystic activity. It is manufactured in the US in the liquid form, or oral suspension, under the brand name Mepron.<ref>{{Cite web |author=GlaxoSmithKline |authorlink=GlaxoSmithKline |title=Mepron |url=http://www.drugs.com/pro/mepron.html |publisher=[[Drugs.com]] |date=June 2015 |access-date=June 22, 2016}}</ref>

==Uses==
Atovaquone is a medication used to treat or prevent:
# For [[pneumocystis pneumonia]] (PCP),<ref name="pmid8479489">{{cite journal |vauthors=Hughes W, Leoung G, Kramer F |title=Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS |journal=N. Engl. J. Med. |volume=328 |issue=21 |pages=1521–7 |date=May 1993 |pmid=8479489 |doi= 10.1056/NEJM199305273282103|url=http://content.nejm.org/cgi/pmidlookup?view=short&pmid=8479489&promo=ONFLNS19|display-authors=etal}}</ref><ref name="pmid7880228">{{cite journal |vauthors=Dohn MN, Weinberg WG, Torres RA |title=Oral atovaquone compared with intravenous pentamidine for Pneumocystis carinii pneumonia in patients with AIDS. Atovaquone Study Group |journal=Ann. Intern. Med. |volume=121 |issue=3 |pages=174–80 |date=August 1994 |pmid=7880228 |doi= 10.7326/0003-4819-121-3-199408010-00003|url=http://www.annals.org/cgi/pmidlookup?view=long&pmid=7880228|display-authors=etal}}</ref> it is used in mild cases, although it is not approved for treatment of severe cases.
# For [[toxoplasmosis]],<ref name="pmid12461021">{{cite journal |vauthors=Djurković-Djaković O, Milenković V, Nikolić A, Bobić B, Grujić J |title=Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii |journal=J. Antimicrob. Chemother. |volume=50 |issue=6 |pages=981–7 |date=December 2002 |pmid=12461021 |doi= 10.1093/jac/dkf251|url=http://jac.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=12461021}}</ref> the medication has antiparasitic and therapeutic effects.
# For [[malaria]], it is one of the two components (along with [[proguanil]]) in the drug [[Malarone]]. Malarone has fewer side effects and is more expensive than [[mefloquine]].<ref>[http://healthlink.mcw.edu/article/979237802.html  Malarone: New Malaria Medication With Fewer Side-effects] {{webarchive |url=https://web.archive.org/web/20060514041931/http://healthlink.mcw.edu/article/979237802.html |date=May 14, 2006 }}</ref> Resistance has been observed.<ref name="pmid12649236">{{cite journal |vauthors=Färnert A, Lindberg J, Gil P |title=Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports |journal=BMJ |volume=326 |issue=7390 |pages=628–9 |date=March 2003 |pmid=12649236 |pmc=151974 |doi=10.1136/bmj.326.7390.628 |url=http://bmj.com/cgi/pmidlookup?view=long&pmid=12649236|display-authors=etal}}</ref>
# For [[babesia]], it is often used in conjunction with oral [[azithromycin]].<ref>{{cite journal
| vauthors=Krause PJ, Lepore T, Sikand VK |title=Atovaquone and azithromycin for the treatment of babesiosis |journal=N. Engl. J. Med. |volume=343 |issue=20 |pages=1454–8 |date=November 2000 |pmid=11078770 |url=http://content.nejm.org/cgi/content/full/343/20/1454
| doi=10.1056/NEJM200011163432004
| display-authors=etal}}</ref>

[[Trimethoprim/sulfamethoxazole]] (TMP-SMX, Bactrim) is generally considered first-line therapy for PCP or toxoplasmosis. However, atovaquone may be used in patients who cannot tolerate, or are allergic to, [[sulfonamide]] medications such as TMP-SMX. In addition, atovaquone has the advantage of not causing [[myelosuppression]], which is an important issue in patients who have undergone [[bone marrow transplantation]].

==Malaria==
Atovaquone, as a [[Atovaquone/proguanil|combination]] preparation with [[proguanil]], has been commercially available from [[GlaxoSmithKline]] since 2000 as Malarone for the treatment and prevention of malaria.

==References==
{{Reflist|2}}

==External links==
{{Commons category|Atovaquone|position=left}}
* [http://www.dartmouth.edu/~blt/Publications/JBC279,2817.pdf#search='Atovaquone' Molecular Basis for Atovaquone Resistance in ''Pneumocystis jirovecii'']
* [http://www.lymenet.de/literatur/atovaquone.htm Atovaquone (Meprone)]
* [http://www.bnf.org British National Formulary]

{{Unibi antiparasitics}}

[[Category:Antimalarial agents]]
[[Category:Antiprotozoal agents]]
[[Category:1,4-Naphthoquinones]]
[[Category:2-Naphthols]]
[[Category:Chloroarenes]]
[[Category:Hydroxynaphthoquinones]]